Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T32CA26029-03
National Institutes of Health
Grant: 5T32GM152349
National Institutes of Health
Grant: 5F31HL152706
National Institutes of Health
Grant: 5T32AI134632
National Science Foundation
Grant: 2139291
Graduate Research Fellowship Program (GRFP)
Memorial Sloan-Kettering Cancer Center
Grant: R01AI148416-S2
US Department of Defense
Grant: CA181350
Canadian Institutes of Health Research
Grant: MM1-174910
NHLBI NIH HHS
Grant: F31 HL152706
NCI NIH HHS
Grant: P50 CA221745
NIAID NIH HHS
Grant: R01 AI148416
NCI NIH HHS
Grant: P30 CA008748
NIGMS NIH HHS
Grant: T32 GM152349
NIAID NIH HHS
Grant: T32 AI134632
NCI NIH HHS
Grant: T32 CA260293
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Royal Society of Canada
Burroughs Wellcome Fund
Ludwig Institute for Cancer Research Ltd
Quebec Health Research Fund
FWCI
16.08
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals